Novonesis will invest €600 million to expand its Patalganga site in India and establish a new enzyme production facility, with operations expected to begin fully by 2030. The project is intended to increase production capacity and strengthen the company’s global supply network.

The Denmark-headquartered company announced the investment on September 2, saying the expanded Patalganga facility will manufacture enzymes for industries including biofuels, household care, and food and beverages.

The project is part of Novonesis’ wider investment programme to expand its global production capabilities. The company said the new facility will also improve its ability to supply customers in India, the Middle East and Africa, markets it expects to grow faster than developed economies in the coming years.

Novonesis President and CEO Ester Baiget described the investment as an important step in the company’s growth strategy and said the expansion would support its long-term production plans.

Chief Operating Officer Anders Lund said increasing demand for biosolutions across industries has made additional production capacity a priority. He added that the Patalganga project is expected to improve operational resilience and supply flexibility while placing production closer to key markets.

The Indian expansion follows investments at Novonesis facilities in Rayong, Thailand; Franklinton, North Carolina; Taicang, China; Araucaria, Brazil; and West Allis, Wisconsin.

Sustainability features are also planned for the Patalganga facility. The site will incorporate freshwater recycling to reduce its use of fresh water, while integrated heat pumps are expected to lower energy requirements. According to the company, these measures will help reduce Scope 1 and Scope 2 emissions.

Novonesis said the Patalganga project will incorporate experience gained from its existing production network as it works toward lower-emission manufacturing.

The company expects the expanded facility to become fully operational in 2030, adding production capacity to its global manufacturing footprint as demand for enzyme-based biosolutions increases.
Source: Novonesis to build next generation enzyme production facility in India | Novonesis